Estee Lauder shares are trading lower following a report suggesting that acne cream products contained high levels of carcinogens.
Portfolio Pulse from Benzinga Newsdesk
Estee Lauder's stock price is trading lower due to a report indicating that its acne cream products have high levels of carcinogens.
March 06, 2024 | 12:56 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Estee Lauder's shares are down following a report about carcinogens in its acne cream products.
The negative report about Estee Lauder's acne cream products directly impacts the company's reputation and could lead to decreased consumer trust and sales, thus negatively affecting the stock price in the short term.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100